SageMedic has developed an ex-vivo live cancer tissue assay to guide cancer therapy that overcomes the limitations of genomic testing.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free